MedTrace Logo

Study Comparing the MiStent SES Versus the XIENCE EES Stent

NCT02385279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1398

Last updated 2023-05-08

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease. The patients will be followed through 3 years for major clinical events.

Conditions

  • Coronary Stenosis

Interventions

DEVICE

MiStent

Percutaneous Coronary Intervention

DEVICE

XIENCE EES

Percutaneous Coronary Intervention

Sponsors & Collaborators

  • Micell Technologies

    collaborator INDUSTRY

  • Stentys

    collaborator INDUSTRY

  • ECRI bv

    lead INDUSTRY

Principal Investigators

  • Ernest Spitzer, MD · European Cardiovascular Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-20
Primary Completion
2017-01-31
Completion
2021-02-04

Countries

  • France
  • Germany
  • Netherlands
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02385279 on ClinicalTrials.gov